Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine.

Vaccine·2022
Same author

IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers.

mSphere·2021
Same author

Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2.

bioRxiv : the preprint server for biology·2020
Same author

Single Copy Transgene Integration in a Transcriptionally Active Site for Recombinant Protein Synthesis.

Biotechnology journal·2018
Same author

A Broad Range of Dose Optima Achieve High-level, Long-term Gene Expression After Hydrodynamic Delivery of Sleeping Beauty Transposons Using Hyperactive SB100x Transposase.

Molecular therapy. Nucleic acids·2016
Same author

Characterization of resistance to rhabdovirus and retrovirus infection in a human myeloid cell line.

PloS one·2015

Related Experiment Video

Updated: Jul 6, 2026

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

Retrovirus vectors.

Patrycja Lech1, Nikunj V Somia

  • 1Department of Genetics Cell Biology and Development, Institute of Human Genetics, Beckman Center for Transposon Research and the Institute of Molecular Virology, University of Minnesota, Minneapolis, Minn., USA.

Contributions to Nephrology
|April 9, 2008
PubMed
Summary

This chapter explores retroviral vectors, focusing on lentiviral vectors for treating kidney diseases. It reviews their design and application for gene transfer to the kidney, highlighting optimization strategies.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Background:

  • Retroviruses and retroviral vectors are key tools in molecular biology.
  • Gene therapy offers potential for treating various diseases, including renal pathologies.
  • Lentiviral vectors are a promising subclass of retroviral vectors for gene delivery.

Purpose of the Study:

  • To outline the concepts and applications of retroviruses and retroviral vectors.
  • To specifically discuss lentiviral vectors for treating renal pathologies.
  • To review vector design and gene transfer efficacy in the kidney.

Main Methods:

  • Review of existing literature on retroviral vectors and gene therapy.
  • Analysis of lentiviral vector design principles.

More Related Videos

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

Related Experiment Videos

Last Updated: Jul 6, 2026

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

  • Evaluation of data on lentiviral vector applications in kidney gene transfer.
  • Main Results:

    • Lentiviral vectors show suitability for gene transfer to the kidney.
    • Vector design considerations are crucial for efficient renal gene delivery.
    • Current data supports the potential of lentiviral vectors in treating kidney diseases.

    Conclusions:

    • Lentiviral vectors represent a viable technology for gene therapy in renal pathologies.
    • Further optimization is needed for effective gene transfer in the complex kidney organ.
    • This technology holds promise for future kidney disease treatments.